WO2002030971A3 - Basb205 polypeptides and polynucleotides coding therefor - Google Patents

Basb205 polypeptides and polynucleotides coding therefor Download PDF

Info

Publication number
WO2002030971A3
WO2002030971A3 PCT/EP2001/011560 EP0111560W WO0230971A3 WO 2002030971 A3 WO2002030971 A3 WO 2002030971A3 EP 0111560 W EP0111560 W EP 0111560W WO 0230971 A3 WO0230971 A3 WO 0230971A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
coding therefor
polynucleotides coding
basb205
basb205 polypeptides
Prior art date
Application number
PCT/EP2001/011560
Other languages
French (fr)
Other versions
WO2002030971A2 (en
Inventor
Joelle Thonnard
Original Assignee
Smithkline Beecham Biolog
Joelle Thonnard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog, Joelle Thonnard filed Critical Smithkline Beecham Biolog
Priority to AU2001295599A priority Critical patent/AU2001295599A1/en
Priority to CA002424938A priority patent/CA2424938A1/en
Priority to US10/399,089 priority patent/US7838003B2/en
Priority to ES01976280T priority patent/ES2305111T3/en
Priority to DK01976280T priority patent/DK1326982T3/en
Priority to EP01976280A priority patent/EP1326982B1/en
Priority to DE60134253T priority patent/DE60134253D1/en
Publication of WO2002030971A2 publication Critical patent/WO2002030971A2/en
Publication of WO2002030971A3 publication Critical patent/WO2002030971A3/en
Priority to US12/891,663 priority patent/US20110129475A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides BASB205 polypeptides and polynucleotides encoding BASB205 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2001/011560 2000-10-13 2001-10-05 Basb205 polypeptides and polynucleotides coding therefor WO2002030971A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AU2001295599A AU2001295599A1 (en) 2000-10-13 2001-10-05 Basb205 polypeptides and polynucleotides coding therefor
CA002424938A CA2424938A1 (en) 2000-10-13 2001-10-05 Basb205 polypeptides and polynucleotides encoding therefor
US10/399,089 US7838003B2 (en) 2000-10-13 2001-10-05 BASB205 polypeptides and polynucleotides from Haemophilus influenzae
ES01976280T ES2305111T3 (en) 2000-10-13 2001-10-05 BASB205 POLYPEPTIDES AND POLINUCLEOTIDES CODING THEM.
DK01976280T DK1326982T3 (en) 2000-10-13 2001-10-05 Therefore, BASB205 polypeptides and polynucleotides coding
EP01976280A EP1326982B1 (en) 2000-10-13 2001-10-05 Basb205 polypeptides and polynucleotides coding therefor
DE60134253T DE60134253D1 (en) 2000-10-13 2001-10-05 BASB205 POLYPEPTIDE AND POLYNUCLEOTIDE ENCODING THEREOF
US12/891,663 US20110129475A1 (en) 2000-10-13 2010-09-27 Basb 205 polypeptides and polynucleotides from haemophilus influenzae

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0025171.0 2000-10-13
GBGB0025171.0A GB0025171D0 (en) 2000-10-13 2000-10-13 Novel compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/891,663 Continuation US20110129475A1 (en) 2000-10-13 2010-09-27 Basb 205 polypeptides and polynucleotides from haemophilus influenzae

Publications (2)

Publication Number Publication Date
WO2002030971A2 WO2002030971A2 (en) 2002-04-18
WO2002030971A3 true WO2002030971A3 (en) 2002-11-07

Family

ID=9901255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011560 WO2002030971A2 (en) 2000-10-13 2001-10-05 Basb205 polypeptides and polynucleotides coding therefor

Country Status (12)

Country Link
US (2) US7838003B2 (en)
EP (2) EP1326982B1 (en)
AT (1) ATE397069T1 (en)
AU (1) AU2001295599A1 (en)
CA (1) CA2424938A1 (en)
CY (1) CY1108280T1 (en)
DE (1) DE60134253D1 (en)
DK (1) DK1326982T3 (en)
ES (1) ES2305111T3 (en)
GB (1) GB0025171D0 (en)
PT (1) PT1326982E (en)
WO (1) WO2002030971A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
CN104436180B (en) 2006-01-17 2021-08-31 阿恩·福斯格伦 Novel surface exposed haemophilus influenzae protein (protein E; pE)
US20150079132A1 (en) * 2013-09-17 2015-03-19 Path Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly
CA3109889A1 (en) * 2018-08-23 2020-02-27 Glaxosmithkline Biologicals Sa Immunogenic proteins and compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033276A1 (en) * 1995-04-21 1996-10-24 Human Genome Sciences, Inc. NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE466259B (en) * 1990-05-31 1992-01-20 Arne Forsgren PROTEIN D - AN IGD BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE, AND THE USE OF THIS FOR ANALYSIS, VACCINES AND PURPOSE
IL111102A0 (en) * 1993-09-29 1994-11-28 Univ New York State Res Found Vaccine for branhamella catarrhalis
GB0025170D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025998D0 (en) * 2000-10-24 2000-12-13 Smithkline Beecham Biolog Novel compounds
WO2002088361A2 (en) * 2001-04-30 2002-11-07 Glaxosmithkline Biologicals S.A. Haemophilus influenzae antigens

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033276A1 (en) * 1995-04-21 1996-10-24 Human Genome Sciences, Inc. NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 9 August 1995 (1995-08-09), FLEISCHMANN RD ET AL.: "Haemophilus influenzae Rd section 153 of 163 of the complete genome.", XP002211705, retrieved from EBI Database accession no. HI32838 *
DATABASE SWALL [online] 1 November 1995 (1995-11-01), FLEISCHMANN R. ET AL: "Probable lipoprotein nlpC homolog precursor.", XP002211706, retrieved from EBI Database accession no. P45296 *
FLEISCHMANN R D ET AL: "WHOLE-GENOME RANDOM SEQUENCING AND ASSEMBLY OF HAEMOPHILUS INFLUENZAE RD", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 269, no. 5223, 28 July 1995 (1995-07-28), pages 496 - 498,507-51, XP000517090, ISSN: 0036-8075 *
TATUSOV R L ET AL: "METABOLISM AND EVOLUTION OF HAEMOPHILUS INFLUENZAE DEDUCED FROM A WHOLE-GENOME COMPARISON WITH ESCHERICHIA COLI", CURRENT BIOLOGY, CURRENT SCIENCE,, GB, vol. 6, no. 3, 1 March 1996 (1996-03-01), pages 279 - 291, XP000857871, ISSN: 0960-9822 *

Also Published As

Publication number Publication date
WO2002030971A2 (en) 2002-04-18
US20040022803A1 (en) 2004-02-05
CA2424938A1 (en) 2002-04-18
AU2001295599A1 (en) 2002-04-22
US20110129475A1 (en) 2011-06-02
CY1108280T1 (en) 2014-02-12
EP1326982B1 (en) 2008-05-28
EP1326982A2 (en) 2003-07-16
DK1326982T3 (en) 2008-09-29
ES2305111T3 (en) 2008-11-01
US7838003B2 (en) 2010-11-23
EP1847609A1 (en) 2007-10-24
PT1326982E (en) 2008-08-13
DE60134253D1 (en) 2008-07-10
GB0025171D0 (en) 2000-11-29
ATE397069T1 (en) 2008-06-15

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
GB9810276D0 (en) Novel compounds
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
GB9820003D0 (en) Novel compounds
AU3164600A (en) Novel compounds
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
GB9809683D0 (en) Novel compounds
GB9810285D0 (en) Novel compounds
GB9812163D0 (en) Novel compounds
WO2000043519A3 (en) Neisseria meningitidis polypeptides
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
AU4567300A (en) Novel compounds
GB0025170D0 (en) Novel compounds
WO2002034772A3 (en) Novel compounds
WO2003010195A3 (en) Novel compounds
GB9918208D0 (en) Novel compounds
WO2002030967A3 (en) Novel compounds
WO2002046215A3 (en) Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
GB9918302D0 (en) Novel compounds
GB9918003D0 (en) Novel compounds
EP2374889A3 (en) Novel compounds
WO2002060938A3 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
WO2002066503A3 (en) H. influenzae antigen basb213
GB9918206D0 (en) Novel compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2424938

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001976280

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001976280

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10399089

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 2001976280

Country of ref document: EP